132 related articles for article (PubMed ID: 5259275)
1. The significance of black eggs in schistosomiasis.
Lambert CR
Ann N Y Acad Sci; 1969 Oct; 160(2):486-90. PubMed ID: 5259275
[No Abstract] [Full Text] [Related]
2. The effects of niridazole in experimental schistosomiasis.
Striebel HP
Ann N Y Acad Sci; 1969 Oct; 160(2):491-518. PubMed ID: 4981049
[No Abstract] [Full Text] [Related]
3. Clinical evaluation of niridazole in Schistosoma mansoni infections.
Prata A
Ann N Y Acad Sci; 1969 Oct; 160(2):660-9. PubMed ID: 5259286
[No Abstract] [Full Text] [Related]
4. Clinical evaluation of niridazole in Schistosoma haematobium and mansoni infections.
Abdallah A; Saif M
Ann N Y Acad Sci; 1969 Oct; 160(2):686-95. PubMed ID: 4898961
[No Abstract] [Full Text] [Related]
5. Factors affecting results of chemotherapy in schistosomiasis.
Jordan P
Ann N Y Acad Sci; 1969 Oct; 160(2):602-11. PubMed ID: 5259281
[No Abstract] [Full Text] [Related]
6. [Development and significance of dead eggs of Schistosoma mansoni in the intestinal wall of mice].
Lambert CR; Striebel H
Ann Soc Belges Med Trop Parasitol Mycol; 1967; 47(2):157-65. PubMed ID: 5628130
[No Abstract] [Full Text] [Related]
7. Laboratory evaluation of antischistosomal agents.
Pellegrino J; Katz N
Ann N Y Acad Sci; 1969 Oct; 160(2):429-60. PubMed ID: 4981048
[No Abstract] [Full Text] [Related]
8. Efficacy of niridazole in schistosomiasis haematobium.
Sankalé M; Baylet R; Moulanier M; Giudicelli J; Aury R; Bourgeade A; Ancelle JP
Ann N Y Acad Sci; 1969 Oct; 160(2):705-12. PubMed ID: 5259288
[No Abstract] [Full Text] [Related]
9. Treatment of schistosomiasis japonica with niridazole.
Yokogawa M; Sano M; Tsuji M; Kojima S; Iijima T; Ito Y
Ann N Y Acad Sci; 1969 Oct; 160(2):933-46. PubMed ID: 4390500
[No Abstract] [Full Text] [Related]
10. Initial experiences with niridazole.
Ramos-Morales F; Correa-Coronas R; De Jesus LG
Ann N Y Acad Sci; 1969 Oct; 160(2):670-85. PubMed ID: 4898960
[No Abstract] [Full Text] [Related]
11. Preliminary studies on porphylaxis, drug resistance, and synergism in experimental schistosomiasis.
Mousa AH; el-Garem A; el-Raziky EH; el-Latif AA; Selim A; Wassef SA; Habib A; el-Shenawy A
Ann N Y Acad Sci; 1969 Oct; 160(2):461-85. PubMed ID: 5259274
[No Abstract] [Full Text] [Related]
12. [Therapeutic evaluation of a derivative of nitrothiazole in schistosomiasis mansoni by a quantitative oogram analysis].
da Cunha AS; Cançado JR
Rev Inst Med Trop Sao Paulo; 1966; 8(6):291-8. PubMed ID: 6011990
[No Abstract] [Full Text] [Related]
13. Elimination of schistosome parasites from man and vector in a hyperendemic area.
Sherif AF
Ann N Y Acad Sci; 1969 Oct; 160(2):885-914. PubMed ID: 5259301
[No Abstract] [Full Text] [Related]
14. Comarative evolution of the fluorescent antibodies directed against the larval stages and the adults of Schistosoma mansoni. II. Experimental schistosomiasis in mice after treatment with niridazole.
Ambroise-Thomas P; Sarasin G; Kien Truong T
Ann Trop Med Parasitol; 1970 Mar; 64(1):93-9. PubMed ID: 4922150
[No Abstract] [Full Text] [Related]
15. The treatment of schistosomiasis with niridazole in Britain.
Kanani SR; Knight R; Woodruff AW
J Trop Med Hyg; 1970 Jul; 73(7):162-9. PubMed ID: 5528390
[No Abstract] [Full Text] [Related]
16. The relation between egg production and worm burden in experimental schistosomiasis. IV. The effect of previous infection.
Koura M
J Egypt Med Assoc; 1972; 55(1):60-8. PubMed ID: 5065712
[No Abstract] [Full Text] [Related]
17. [Results of an anti-schistosoma campaign in Londrina, Paraná. Use of ambilhar (Ciba 32.644-Ba) on 219 Schistosoma mansoni carriers].
Ferraz AS
Rev Bras Malariol Doencas Trop; 1969; 21(1):161-86. PubMed ID: 5376929
[No Abstract] [Full Text] [Related]
18. Some observations on the use of niridazole (Ciba 32,644-Ba, Ambilhar) in the treatment of Schistosoma mansoni infections in Mwanza, Tanzania.
Eyakuze VM
East Afr Med J; 1968 Mar; 45(3):147-52. PubMed ID: 5658192
[No Abstract] [Full Text] [Related]
19. Experimental chemotherapy of Schistosomiasis mansoni.
Pellegrino J; Katz N
Adv Parasitol; 1968; 6():233-90. PubMed ID: 4978052
[No Abstract] [Full Text] [Related]
20. Risks versus benefits in antischistosomal therapy.
Fontanilles F
Ann N Y Acad Sci; 1969 Oct; 160(2):811-20. PubMed ID: 5259299
[No Abstract] [Full Text] [Related]
[Next] [New Search]
